Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Cabaletta Bio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −14 vs. Q4 2024
- Shares held
- 36.3M
- −1.69M (−4.5%) vs. Q4 2024
- Total value
- $50.3M
- −$35.9M (−41.6%) vs. Q4 2024
- New holders
- 16
- 28 more added
- Sold out
- 30
- 33 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CABA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 139 | $490.4M |
| Q1 2026 | 108 | $227.5M |
| Q4 2025 | 95 | $166.9M |
| Q3 2025 | 75 | $162.0M |
| Q2 2025 | 86 | $110.7M |
| Q1 2025 | 93 | $50.3M |
| Q4 2024 | 109 | $87.2M |
| Q3 2024 | 120 | $226.7M |
| Q2 2024 | 142 | $380.0M |
| Q1 2024 | 159 | $870.9M |
| Q4 2023 | 128 | $1.10B |
| Q3 2023 | 97 | $622.6M |
| Q2 2023 | 84 | $470.5M |
| Q1 2023 | 72 | $203.9M |
| Q4 2022 | 61 | $183.9M |
| Q3 2022 | 54 | $7.76M |
| Q2 2022 | 55 | $17.8M |
| Q1 2022 | 62 | $36.9M |
| Q4 2021 | 66 | $68.9M |
| Q3 2021 | 61 | $211.3M |
| Q2 2021 | 63 | $135.5M |
| Q1 2021 | 68 | $180.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cabaletta Bio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 0 | $0 | 0.00% | −110,988−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −75,400−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −67,435−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −54,949−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −20,604−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,527−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −16,999−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −16,604−100.0% | Sold out |
| Miller Financial Services LLC | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,637−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −11,755−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,001−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −4,250−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,574−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −712−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −380−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| WR Wealth Planners, LLC | – | – | – | – | Not filed |